Compazine and Viibryd drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Compazine (prochlorperazine maleate) and Viibryd (vilazodone hydrochloride). Common drug interactions include diarrhoea among females and haemoglobin decreased among males.

The phase IV clinical study analyzes what interactions people have when they take Compazine and Viibryd. It is created by eHealthMe based on reports of 31 people who take the same drugs from the FDA, and is updated regularly.

What is Compazine?

Compazine has active ingredients of prochlorperazine maleate. It is often used in nausea and vomiting. eHealthMe is studying from 13,646 Compazine users. Check the latest studies of Compazine.

What is Viibryd?

Viibryd has active ingredients of vilazodone hydrochloride. It is often used in depression. eHealthMe is studying from 11,106 Viibryd users. Check the latest studies of Viibryd.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 03, 2026

31 people who take Compazine and Viibryd together, and have interactions are studied.

Compazine and Viibryd drug interactions.

What are the common drug interactions of Compazine and Viibryd, by gender? *:

female:

  1. Diarrhoea
  2. Back pain
  3. Dyspnoea (difficult or laboured respiration)
  4. Fatigue (feeling of tiredness)
  5. Pain
  6. Abdominal discomfort
  7. Abdominal pain
  8. Anaemia (lack of blood)
  9. Bladder irritation
  10. Constipation

male:

  1. Haemoglobin decreased
  2. Asthenia (weakness)
  3. Panic attack
  4. Pneumonitis (inflammation of the walls of the alveoli in the lungs)
  5. Pyrexia (fever)
  6. Respiratory failure (inadequate gas exchange by the respiratory system)
  7. Weight increased
  8. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  9. Decreased appetite
  10. Dizziness

What are the common drug interactions of Compazine and Viibryd, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Back pain
  2. Dizziness
  3. Fatigue (feeling of tiredness)
  4. Pain
  5. Abdominal pain
  6. Adrenomegaly (enlarged adrenal glands)
  7. Anaemia (lack of blood)
  8. Apnoea (suspension of external breathing)
  9. Bipolar ii disorder (characterized by at least one episode of hypomania and at least one episode of major depression)
  10. Bone pain

50-59:

  1. Anaemia (lack of blood)
  2. Diverticulitis (digestive disease which involves the formation of pouches (diverticula) within the bowel wall)
  3. Ewing's sarcoma (malignant small, round, blue cell tumour)
  4. Peripheral swelling

60+:

  1. Abdominal discomfort
  2. Bladder irritation
  3. Joint injury
  4. Pneumonitis (inflammation of the walls of the alveoli in the lungs)
  5. Pyrexia (fever)
  6. Respiratory failure (inadequate gas exchange by the respiratory system)
  7. Decreased appetite
  8. Diarrhoea
  9. Dry eye (lack of adequate tears)
  10. Hysterectomy

What are the existing conditions these people have? *

  1. Multiple Myeloma (cancer of the plasma cells): 8 people, 25.81%
  2. Malignant Peritoneal Neoplasm (cancer tumour of peritoneum): 8 people, 25.81%
  3. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 5 people, 16.13%
  4. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 5 people, 16.13%
  5. Migraine (headache): 3 people, 9.68%
  6. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 3 people, 9.68%
  7. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 9.68%
  8. Waldenstrom's Macroglobulinaemia (cancer affects small lymphocytes (white blood cells)): 2 people, 6.45%
  9. Stress And Anxiety: 2 people, 6.45%
  10. Seizures (abnormal excessive or synchronous neuronal activity in the brain): 2 people, 6.45%

* Approximation only. Some reports may have incomplete information.

Do you take Compazine and Viibryd?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Compazine and Viibryd:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Compazine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Viibryd:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Compazine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Viibryd and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on prochlorperazine maleate and vilazodone hydrochloride (the active ingredients of Compazine and Viibryd, respectively), and Compazine and Viibryd (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: